Last checked at 7 Mar 2024 13:52
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 7 March 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 25 February 2022 under the 2014 Executive Incentive Plan ("EIP") Element B and 25 February 2021 under the EIP Element C.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Bassam Kanaan
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Bassam Kanaan | |
2 | Reason for the notification | ||
a) | Position/status | PDMR | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Hikma Pharmaceuticals PLC | |
b) | LEI | 549300BNS685UXH4JI75 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil | EIP Award, Element B: 20,588 | ||
Nil | EIP Award, Element C: 13,378 | ||
d) | Aggregated information | Price(s): nil Volume(s): 33,966 | |
e) | Date of the transaction | 6 March 2024 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
Julie Hill
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Julie Hill | |
2 | Reason for the notification | ||
a) | Position/status | PDMR | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Hikma Pharmaceuticals PLC | |
b) | LEI | 549300BNS685UXH4JI75 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares acquired from the vesting of conditional awards under the EIP Element B. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil | 5,339 | ||
d) | Aggregated information | Price(s): nil Volume(s): 5,339
| |
e) | Date of the transaction | 6 March 2024 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares sold to cover tax following the vesting of conditional awards under the EIP Element B. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
£19.275 | 2,190 | ||
d) | Aggregated information | Price(s): £19.275 Volume(s): 2,190 Total(s): £42,211.36
| |
e) | Date of the transaction | 6 March 2024 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
Helen MiddlemistGroup Company Secretary
+44 (0)20 7399 2760
7 March 2024